Addex

Allosteric modulators for human health

  • About us
    • Addex Corporate Presentation
    • Overview
    • Our people
      • Executive Officers
      • Non-Executive Directors
      • Scientific Advisory Board
    • Contact
    • Privacy Policy
    • Careers
  • Pipeline
    • Clinical and Pre-Clinical Pipeline
    • Research And Development
  • Technology platform
    • Allosteric modulation
    • Our capabilities
      • Screening Assays
      • Chemistry
    • Publications
  • Partners & collaboration
  • Investors
    • Addex Corporate Presentation
    • Stock Data
    • Press releases
    • Ad hoc announcements (Art. 53 L.R)
    • Events
    • Financial Reports
    • Analyst Reports
    • General Meetings
    • SEC / SIX Filings
    • Guide to US ADSS for Six Shareholders
    • Register for email news
    • Corporate Governance
    • Contact
  • Media
    • Press releases
    • Contact

Financial Reports

  • 2022 Annual Report & Quarter 3 Report & Half Year Report & Quarter 1 Report
  • 2021 Annual Report & Quarter 3 Report & Half Year Report & Quarter 1 Report
  • 2020 Annual Report & Quarter 3 Report & Half Year Report & Quarter 1 Report
  • 2019 Annual Report & Half Year Report
  • 2018 Annual Report & Half Year Report
  • 2017 Annual Report & Half Year Report
  • 2016 Annual Report & Half Year Report
  • 2015 Annual Report & Half Year Report
  • 2014 Annual Report & Half Year Report
  • 2013 Annual Report & Half Year Report
  • 2012 Annual Report & Half Year Report
  • 2011 Annual Report & Half Year Report
  • 2010 Annual Report & Half Year Report
  • 2009 Annual Report & Half Year Report
  • 2008 Annual Report & Half Year Report
  • 2007 Annual Report & Half Year Report
2023 © Addex therapeutics